An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Abstract Background Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patients with melanoma. However, prospe...
Main Authors: | Ryan J. Sullivan, Michael B. Atkins, John M. Kirkwood, Sanjiv S. Agarwala, Joseph I. Clark, Marc S. Ernstoff, Leslie Fecher, Thomas F. Gajewski, Brian Gastman, David H. Lawson, Jose Lutzky, David F. McDermott, Kim A. Margolin, Janice M. Mehnert, Anna C. Pavlick, Jon M. Richards, Krista M. Rubin, William Sharfman, Steven Silverstein, Craig L. Slingluff, Vernon K. Sondak, Ahmad A. Tarhini, John A. Thompson, Walter J. Urba, Richard L. White, Eric D. Whitman, F. Stephen Hodi, Howard L. Kaufman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2018-05-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-018-0362-6 |
Similar Items
-
The use of immunotherapy in the treatment of melanoma
by: Tala Achkar, et al.
Published: (2017-04-01) -
Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
by: Anjali Rohatgi, et al.
Published: (2021-03-01) -
Cytokines in Cancer Immunotherapy
by: Sylvia Lee, et al.
Published: (2011-10-01) -
Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011
by: Forero Ivan, et al.
Published: (2012-05-01) -
Exploring the emerging role of the microbiome in cancer immunotherapy
by: Jessica Fessler, et al.
Published: (2019-04-01)